DE60134387D1 - Pseudoephedrin und fexofenadine enthaltende osmotische vorrichtung - Google Patents

Pseudoephedrin und fexofenadine enthaltende osmotische vorrichtung

Info

Publication number
DE60134387D1
DE60134387D1 DE60134387T DE60134387T DE60134387D1 DE 60134387 D1 DE60134387 D1 DE 60134387D1 DE 60134387 T DE60134387 T DE 60134387T DE 60134387 T DE60134387 T DE 60134387T DE 60134387 D1 DE60134387 D1 DE 60134387D1
Authority
DE
Germany
Prior art keywords
pseudoephedrine
osmotic device
containing osmotic
fexofenadine
fexofenadine containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134387T
Other languages
English (en)
Inventor
Joaquina Faour
Marcelo A Ricci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osmotica Kereskedelmi es Szolgaltato KFT
Original Assignee
Osmotica Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osmotica Corp filed Critical Osmotica Corp
Application granted granted Critical
Publication of DE60134387D1 publication Critical patent/DE60134387D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
DE60134387T 2000-01-13 2001-01-08 Pseudoephedrin und fexofenadine enthaltende osmotische vorrichtung Expired - Lifetime DE60134387D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17587800P 2000-01-13 2000-01-13
US09/725,655 US6613357B2 (en) 2000-01-13 2000-11-29 Osmotic device containing pseudoephedrine and an H1 antagonist
PCT/US2001/000528 WO2001051038A1 (en) 2000-01-13 2001-01-08 Osmotic device containing pseudoephedrine and an h1 antagonist

Publications (1)

Publication Number Publication Date
DE60134387D1 true DE60134387D1 (de) 2008-07-24

Family

ID=26871655

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134387T Expired - Lifetime DE60134387D1 (de) 2000-01-13 2001-01-08 Pseudoephedrin und fexofenadine enthaltende osmotische vorrichtung

Country Status (12)

Country Link
US (1) US6613357B2 (de)
EP (1) EP1246612B1 (de)
AR (1) AR026818A1 (de)
AT (1) ATE397917T1 (de)
AU (1) AU2001226349A1 (de)
BR (1) BR0107596A (de)
CA (1) CA2396145C (de)
DE (1) DE60134387D1 (de)
ES (1) ES2307584T3 (de)
MX (1) MXPA02006867A (de)
UY (1) UY26525A1 (de)
WO (1) WO2001051038A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307887A1 (en) * 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
PE20020324A1 (es) * 2000-10-06 2002-06-18 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
EP1240897B1 (de) * 2001-03-14 2006-06-21 Pfizer Products Inc. Pharmazeutische Tablette und eine Verfahren zu deren Herstellung
WO2004019917A1 (es) * 2002-08-29 2004-03-11 Osmotica Corp. Dispositivo de liberacion de droga que contiene oseltamivir y un antagonista h1
JP2010180238A (ja) * 2001-11-22 2010-08-19 Daiichi Sankyo Healthcare Co Ltd 鼻炎用組成物
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
EP1350512A1 (de) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Formulierung für ein Kombinationspräparat mit Epinastine, Belladonna und Pseudoephedrin
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
AU2003250073A1 (en) * 2002-08-02 2004-02-25 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
WO2004087095A2 (es) * 2003-03-31 2004-10-14 Osmotica Costa Rica, Sociedad Anonima Dispositivo osmótico que contiene zafirlukast y un antagonista h1
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050208108A1 (en) * 2004-03-19 2005-09-22 Jannusch Leonard C Thermoplastic films and methods for making
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US8574626B2 (en) 2004-12-03 2013-11-05 Osmotica Kereskedelmi és Szolgáltató KFT Osmotic device containing amantadine and an osmotic salt
US8252331B2 (en) * 2004-12-03 2012-08-28 Osmotica Kereskedelmi és Szolgáltató, KFT Osmotic device containing amantadine and an osmotic salt
ATE489079T1 (de) * 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
KR20090016612A (ko) * 2006-06-30 2009-02-16 테바 파마슈티컬 인더스트리즈 리미티드 피페리디노알칸올 및 충혈완화제의 복합제를 포함하는 약학조성물
JP2009543780A (ja) * 2006-07-11 2009-12-10 ミューチュアル ファーマシューティカル カンパニー，インク． 制御放出製剤およびキット
US20080085311A1 (en) * 2006-10-05 2008-04-10 Tripathi Sanjay S Antihistamine-decongestant combinations
US20100143471A1 (en) * 2007-03-21 2010-06-10 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
EP2173329A1 (de) * 2007-07-03 2010-04-14 Synthon B.V. Tolterodinkügelchen
US8450349B2 (en) 2007-09-13 2013-05-28 E5 Pharma LLC Long acting dual release product containing carbinoxamine and pseudoephedrine
EP2364143A1 (de) * 2008-10-31 2011-09-14 McNeil-PPC, Inc. Osmotische tablette mit komprimierter aussenbeschichtung
CA2750196C (en) * 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
CA2748783A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010078543A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer
WO2010140111A1 (en) 2009-06-02 2010-12-09 Ranbaxy Laboratories Limited Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
RU2018141241A (ru) 2012-11-30 2019-01-24 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
CN103554985B (zh) * 2013-10-18 2015-11-18 苏州大学 一种可反复开闭的双开关响应控制的分子释放系统、制备方法及应用
AU2015237723B2 (en) 2014-03-26 2018-04-26 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US10213394B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US20190247331A1 (en) 2018-02-15 2019-08-15 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US10213393B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság Composition and method for treating neurological disease
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
EP0811374A1 (de) * 1996-05-29 1997-12-10 Pfizer Inc. Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
IN186245B (de) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
IN188720B (de) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
JP2003509439A (ja) * 1999-09-14 2003-03-11 スミスクライン・ビーチャム・コーポレイション 水性コーティングされたビーズレットの製法
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

Also Published As

Publication number Publication date
UY26525A1 (es) 2001-09-28
ATE397917T1 (de) 2008-07-15
US20020102305A1 (en) 2002-08-01
US6613357B2 (en) 2003-09-02
AR026818A1 (es) 2003-02-26
AU2001226349A1 (en) 2001-07-24
BR0107596A (pt) 2002-11-19
CA2396145C (en) 2008-07-22
CA2396145A1 (en) 2001-07-19
MXPA02006867A (es) 2004-04-02
ES2307584T3 (es) 2008-12-01
EP1246612A1 (de) 2002-10-09
WO2001051038A1 (en) 2001-07-19
EP1246612A4 (de) 2006-04-05
EP1246612B1 (de) 2008-06-11

Similar Documents

Publication Publication Date Title
DE60134387D1 (de) Pseudoephedrin und fexofenadine enthaltende osmotische vorrichtung
ATE553752T1 (de) Venlafaxin und einen antipsychotischen wirkstoff enthaltende osmotische vorrichtung
DE60136946D1 (de) Mehrfach feuerbare ftrd-resektionsvorrichtung
DE60131258D1 (de) Trainingsgerät
DE50112910D1 (de) Navigationsverfahren und -vorrichtung
DE60111433D1 (de) Lötverfahren und Lötvorrichtung
DE60127017D1 (de) Aufschlämmungsrückfluss-Vorrichtung
DE60142600D1 (de) Entwicklungsverfahren und -vorrichtung
DE50111798D1 (de) Nähvorrichtung
DE60140232D1 (de) Eine eintauchende Anzeigevorrichtung
DE60037682D1 (de) Abbildungsvorrichtung
NO20005524L (no) Ror-i-roranordning
DE50105681D1 (de) Wiederablösbare selbstklebende Vorrichtung
DE50002785D1 (de) Längliche stempelvorrichtung
DE60026363D1 (de) Elektroforetische trennungsvorrichtung und zugehöriges verwendungsverfahren
DE60134222D1 (de) Biegeverfahren und Biegevorrichtung
DE60003356D1 (de) Stanzvorrichtung
DE60016929D1 (de) Toastgerät
FI20000943A (fi) Kääntölaite
DE50110746D1 (de) Wiederablösbare Vorrichtung
ITMI20000340A0 (it) Metodo e dispositivo per saldatura
DE60205008D1 (de) Kettelverfahren und -vorrichtung
ATA6512000A (de) Trainingsgerät
DE29901236U1 (de) Stanzvorrichtung
ATA20952000A (de) Haltevorrichtung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT, BUDA, HU